{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T11:28:11Z","timestamp":1775302091977,"version":"3.50.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","interventional.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.iccl.2019.05.002","type":"journal-article","created":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T07:21:08Z","timestamp":1564212068000},"page":"341-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transcatheter Closure of Patent Foramen Ovale"],"prefix":"10.1016","volume":"8","author":[{"given":"Angelos","family":"Arfaras-Melainis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonidas","family":"Palaiodimos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad K.","family":"Mojadidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.iccl.2019.05.002_bib1","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics---2017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.iccl.2019.05.002_bib2","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM198805053181802","article-title":"Prevalence of patent foramen ovale in patients with stroke","volume":"318","author":"Lechat","year":"1988","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.iccl.2019.05.002_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0025-6196(12)60336-X","article-title":"Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts","volume":"59","author":"Hagen","year":"1984","journal-title":"Mayo Clin Proc"},{"issue":"8601","key":"10.1016\/j.iccl.2019.05.002_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0140-6736(88)92944-3","article-title":"Patent foramen ovale in young stroke patients","volume":"2","author":"Webster","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.iccl.2019.05.002_bib5","first-page":"134","article-title":"Thrombose und embolie","volume":"vol. 1","author":"Cohnheim","year":"1877"},{"issue":"3","key":"10.1016\/j.iccl.2019.05.002_bib6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/jcp.4.3.316","article-title":"Paradoxical embolism","volume":"4","author":"Johnson","year":"1951","journal-title":"J\u00a0Clin Pathol"},{"issue":"11","key":"10.1016\/j.iccl.2019.05.002_bib7","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S0002-9149(00)00772-4","article-title":"Prevalence of patent foramen ovale in patients with acute myocardial infarction and angiographically normal coronary arteries","volume":"85","author":"Crump","year":"2000","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.iccl.2019.05.002_bib8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1378\/chest.108.2.549","article-title":"Paradoxical embolism: an underrecognized problem","volume":"108","author":"Ward","year":"1995","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.iccl.2019.05.002_bib9","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/01.STR.31.10.2407","article-title":"Morphological and functional characteristics of patent foramen ovale and their embolic implications","volume":"31","author":"De Castro","year":"2000","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.iccl.2019.05.002_bib10","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/01.STR.18.5.856","article-title":"Atrial septal aneurysm: association with cerebrovascular and peripheral embolic events","volume":"18","author":"Belkin","year":"1987","journal-title":"Stroke"},{"issue":"24","key":"10.1016\/j.iccl.2019.05.002_bib11","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJMoa011503","article-title":"Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both","volume":"345","author":"Mas","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.iccl.2019.05.002_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.echo.2003.12.003","article-title":"Persisting Eustachian valve in adults: relation to patent foramen ovale and cerebrovascular events","volume":"17","author":"Schuchlenz","year":"2004","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"5","key":"10.1016\/j.iccl.2019.05.002_bib13","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s10072-011-0567-7","article-title":"Prominent persisting Eustachian valve initiates spontaneous right-to-left shunt and paradoxical embolism in a patient with patent foramen ovale","volume":"32","author":"Kato","year":"2011","journal-title":"Neurol Sci"},{"issue":"22","key":"10.1016\/j.iccl.2019.05.002_bib14","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.jacc.2017.09.1105","article-title":"Percutaneous closure of patent foramen ovale in patients with migraine: The PREMIUM Trial","volume":"70","author":"Tobis","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"26","key":"10.1016\/j.iccl.2019.05.002_bib15","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/eurheartj\/ehw027","article-title":"Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial","volume":"37","author":"Mattle","year":"2016","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.iccl.2019.05.002_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/CRD.0000000000000205","article-title":"Patent foramen ovale and hypoxemia","volume":"27","author":"Mojadidi","year":"2019","journal-title":"Cardiol Rev"},{"issue":"9","key":"10.1016\/j.iccl.2019.05.002_bib17","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jacc.2017.12.059","article-title":"Cryptogenic stroke and patent foramen ovale","volume":"71","author":"Mojadidi","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8637","key":"10.1016\/j.iccl.2019.05.002_bib18","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0140-6736(89)90064-0","article-title":"Patent foramen ovale and decompression sickness in divers","volume":"333","author":"Moon","year":"1989","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.iccl.2019.05.002_bib19","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.5664\/jcsm.5190","article-title":"Sleep apnea in patients with and without a right-to-left shunt","volume":"11","author":"Mojadidi","year":"2015","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"10","key":"10.1016\/j.iccl.2019.05.002_bib20","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ejim.2015.09.017","article-title":"Patent foramen ovale: unanswered questions","volume":"26","author":"Mojadidi","year":"2015","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.iccl.2019.05.002_bib21","first-page":"701","article-title":"The effect of patent foramen ovale closure in patients with platypnea-orthodeoxia syndrome","volume":"86","author":"Mojadidi","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.iccl.2019.05.002_bib22","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jcin.2012.03.013","article-title":"The effect of patent foramen ovale closure on visual aura without headache or typical aura with migraine headache","volume":"5","author":"Khessali","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.iccl.2019.05.002_bib23","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1161\/01.CIR.86.6.1902","article-title":"Transcatheter closure of patent foramen ovale after presumed paradoxical embolism","volume":"86","author":"Bridges","year":"1992","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.iccl.2019.05.002_bib24","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcin.2012.02.021","article-title":"Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism","volume":"5","author":"Agarwal","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.iccl.2019.05.002_bib25","first-page":"495","article-title":"Identification and quantification of patent foramen ovale-mediated shunts: echocardiography and transcranial Doppler","volume":"6","author":"Mahmoud","year":"2017","journal-title":"Interv Cardiol Clin"},{"issue":"6","key":"10.1016\/j.iccl.2019.05.002_bib26","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/eurheartj\/ehr443","article-title":"Secondary stroke prevention: patent foramen ovale, aortic plaque, and carotid stenosis","volume":"33","author":"Meier","year":"2012","journal-title":"Eur Heart J"},{"issue":"Suppl X","key":"10.1016\/j.iccl.2019.05.002_bib27","article-title":"Patent foramen ovale: indications for closure and techniques","volume":"12","author":"Taramasso","year":"2016","journal-title":"EuroIntervention"},{"issue":"6","key":"10.1016\/j.iccl.2019.05.002_bib28","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/echo.12462","article-title":"Diagnostic accuracy of transesophageal echocardiogram for the detection of patent foramen ovale: a meta-analysis","volume":"31","author":"Mojadidi","year":"2014","journal-title":"Echocardiography"},{"issue":"3","key":"10.1016\/j.iccl.2019.05.002_bib29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4244\/EIJV9I3A61","article-title":"Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices---influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study","volume":"9","author":"Marchese","year":"2013","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.iccl.2019.05.002_bib30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jcmg.2013.12.011","article-title":"Accuracy of transcranial Doppler for the diagnosis of intracardiac right-to-left shunt: a bivariate meta-analysis of prospective studies","volume":"7","author":"Mojadidi","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.iccl.2019.05.002_bib31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.0742-2822.2004.02168.x","article-title":"Harmonic imaging improves sensitivity at the expense of specificity in the detection of patent foramen ovale","volume":"21","author":"Madala","year":"2004","journal-title":"Echocardiography"},{"issue":"9","key":"10.1016\/j.iccl.2019.05.002_bib32","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/echo.12583","article-title":"Accuracy of conventional transthoracic echocardiography for the diagnosis of intracardiac right-to-left shunt: a meta-analysis of prospective studies","volume":"31","author":"Mojadidi","year":"2014","journal-title":"Echocardiography"},{"issue":"5","key":"10.1016\/j.iccl.2019.05.002_bib33","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s10554-014-0426-8","article-title":"Two-dimensional echocardiography using second harmonic imaging for the diagnosis of intracardiac right-to-left shunt: a meta-analysis of prospective studies","volume":"30","author":"Mojadidi","year":"2014","journal-title":"Int J Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.iccl.2019.05.002_bib34","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/hs0302.104543","article-title":"Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study","volume":"33","author":"Lamy","year":"2002","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.iccl.2019.05.002_bib35","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"368","author":"Carroll","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.iccl.2019.05.002_bib36","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.iccl.2019.05.002_bib37","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.iccl.2019.05.002_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2047-783X-16-1-13","article-title":"Risk and fate of residual interatrial shunting after transcatheter closure of patent foramen ovale: a long term follow up study","volume":"16","author":"Hammerstingl","year":"2011","journal-title":"Eur J Med Res"},{"issue":"3","key":"10.1016\/j.iccl.2019.05.002_bib39","first-page":"455","article-title":"Comparison of residual shunt rates in five devices used to treat patent foramen ovale","volume":"84","author":"Matsumura","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2019.05.002_bib40","series-title":"Device closure of patent foramen ovale or medical therapy for cryptogenic stroke: the CLOSURE I trial. Patent foramen ovale","first-page":"173","author":"Mojadidi","year":"2015"},{"issue":"11","key":"10.1016\/j.iccl.2019.05.002_bib41","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"43","key":"10.1016\/j.iccl.2019.05.002_bib42","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1093\/eurheartj\/eht285","article-title":"Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials","volume":"34","author":"Rengifo-Moreno","year":"2013","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.iccl.2019.05.002_bib43","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jcin.2013.08.001","article-title":"Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis","volume":"6","author":"Khan","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.iccl.2019.05.002_bib44","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jacc.2015.12.023","article-title":"Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials","volume":"67","author":"Kent","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.iccl.2019.05.002_bib46","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"Sondergaard","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.iccl.2019.05.002_bib47","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.iccl.2019.05.002_bib48","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","article-title":"Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial","volume":"71","author":"Lee","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.iccl.2019.05.002_bib49","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.carrev.2018.02.014","article-title":"Percutaneous closure of patent foramen ovale vs. medical treatment for patients with history of cryptogenic stroke: a systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Palaiodimos","year":"2018","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.iccl.2019.05.002_bib50","series-title":"Percutaneous closure of patent foramen ovale vs. medical treatment for patients with history of cryptogenic stroke-a systematic review and meta-analysis of randomised controlled trials. Cerebrovascular Diseases","year":"2018"},{"issue":"21","key":"10.1016\/j.iccl.2019.05.002_bib51","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.jcin.2017.09.002","article-title":"Transcatheter patent foramen ovale closure after cryptogenic stroke: an updated meta-analysis of randomized trials","volume":"10","author":"Mojadidi","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.iccl.2019.05.002_bib52","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jacc.2018.03.549","article-title":"Cryptogenic stroke and patent foramen ovale: ready for prime time?","volume":"72","author":"Mojadidi","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.iccl.2019.05.002_bib53","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/STROKEAHA.117.020030","article-title":"Closure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or transient ischemic attack: updated systematic review and meta-analysis","volume":"49","author":"Ntaios","year":"2018","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.iccl.2019.05.002_bib54","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/M17-3033","article-title":"Percutaneous closure versus medical treatment in stroke patients with patent foramen ovale: a systematic review and meta-analysis","volume":"168","author":"De Rosa","year":"2018","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.iccl.2019.05.002_bib55","first-page":"578","article-title":"Patent foramen ovale closure versus medical therapy in cases with cryptogenic stroke, meta-analysis of randomized controlled trials","volume":"265","author":"Abo-salem","year":"2018","journal-title":"J\u00a0Neurol"},{"issue":"5","key":"10.1016\/j.iccl.2019.05.002_bib56","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/M17-2679","article-title":"Device closure versus medical therapy alone for patent foramen ovale in patients with cryptogenic stroke: a systematic review and meta-analysis","volume":"168","author":"Shah","year":"2018","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.iccl.2019.05.002_bib57","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.amjmed.2017.11.027","article-title":"Patent foramen ovale closure for secondary prevention of cryptogenic stroke: updated meta-analysis of randomized clinical trials","volume":"131","author":"Vaduganathan","year":"2018","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.iccl.2019.05.002_bib58","doi-asserted-by":"crossref","first-page":"e008356","DOI":"10.1161\/JAHA.117.008356","article-title":"Closure, anticoagulation, or antiplatelet therapy for cryptogenic stroke with patent foramen ovale: systematic review of randomized trials, sequential meta-analysis, and new insights from the CLOSE study","volume":"7","author":"Turc","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"5\u20136","key":"10.1016\/j.iccl.2019.05.002_bib59","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000488401","article-title":"Patent foramen ovale and cryptogenic stroke or transient ischemic attack: to close or not to close? A systematic review and meta-analysis","volume":"45","author":"Lattanzi","year":"2018","journal-title":"Cerebrovasc Dis"},{"issue":"18","key":"10.1016\/j.iccl.2019.05.002_bib60","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1093\/eurheartj\/ehy121","article-title":"Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials","volume":"39","author":"Ahmad","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2019.05.002_bib61","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ahj.2018.01.008","article-title":"Transcatheter closure of patent foramen ovale following cryptogenic stroke: an updated meta-analysis of randomized controlled trials","volume":"199","author":"Riaz","year":"2018","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.iccl.2019.05.002_bib62","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.acvd.2018.06.001","article-title":"The best DEFENSE for high-risk patent foramen ovale: an updated meta-analysis of six randomized trials","volume":"112","author":"Kokkinidis","year":"2018","journal-title":"Arch Cardiovasc Dis"},{"issue":"5","key":"10.1016\/j.iccl.2019.05.002_bib63","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jcin.2011.01.009","article-title":"Explantation of patent foramen ovale closure devices: a multicenter survey","volume":"4","author":"Verma","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.iccl.2019.05.002_bib64","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.amjcard.2018.05.035","article-title":"Atrial fibrillation after percutaneous patent foramen ovale closure","volume":"122","author":"Mojadidi","year":"2018","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.iccl.2019.05.002_bib65","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.amjcard.2017.11.037","article-title":"Meta-analysis comparing patent foramen ovale closure versus medical therapy to prevent recurrent cryptogenic stroke","volume":"121","author":"Ando","year":"2018","journal-title":"Am J Cardiol"},{"issue":"17","key":"10.1016\/j.iccl.2019.05.002_bib66","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.4244\/EIJ-D-18-00767","article-title":"New-onset atrial fibrillation following percutaneous patent foramen ovale closure: a systematic review and meta-analysis of randomised trials","volume":"14","author":"Elgendy","year":"2019","journal-title":"EuroIntervention"},{"issue":"6","key":"10.1016\/j.iccl.2019.05.002_bib67","first-page":"889","article-title":"New onset atrial fibrillation after patent foramen ovale closure","volume":"74","author":"Staubach","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2019.05.002_bib68","first-page":"1","article-title":"Percutaneous transcatheter closure of high-risk patent foramen ovale in the elderly","author":"Takafuji","year":"2019","journal-title":"Heart Vessels"},{"issue":"26","key":"10.1016\/j.iccl.2019.05.002_bib69","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.iccl.2019.05.002_bib70","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","article-title":"Atrial fibrillation in patients with cryptogenic stroke","volume":"370","author":"Gladstone","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.iccl.2019.05.002_bib71","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: the case for a new clinical construct","volume":"13","author":"Hart","year":"2014","journal-title":"Lancet Neurol"},{"issue":"20","key":"10.1016\/j.iccl.2019.05.002_bib72","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa011258","article-title":"A\u00a0comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke","volume":"345","author":"Mohr","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.iccl.2019.05.002_bib73","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for\u00a0stroke prevention after embolic stroke of undetermined source","volume":"378","author":"Hart","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.iccl.2019.05.002_bib75","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.CIR.0000017498.88393.44","article-title":"Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study","volume":"105","author":"Homma","year":"2002","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.iccl.2019.05.002_bib76","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1474-4422(18)30319-3","article-title":"Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial","volume":"17","author":"Kasner","year":"2018","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.iccl.2019.05.002_bib77","doi-asserted-by":"crossref","first-page":"e023761","DOI":"10.1136\/bmjopen-2018-023761","article-title":"Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence","volume":"8","author":"Mir","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.iccl.2019.05.002_bib78","doi-asserted-by":"crossref","first-page":"k2515","DOI":"10.1136\/bmj.k2515","article-title":"Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline","volume":"362","author":"Kuijpers","year":"2018","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.iccl.2019.05.002_bib79","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.amjcard.2019.01.043","article-title":"Impact of discontinuation of antithrombotic therapy following closure of patent foramen ovale in patients with cryptogenic embolism","volume":"123","author":"Wintzer-Wehekind","year":"2019","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.iccl.2019.05.002_bib81","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.iccl.2019.05.002_bib82","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/1747493017743062","article-title":"Canadian stroke best practice recommendations: secondary prevention of stroke, practice guidelines, update 2017","volume":"13","author":"Wein","year":"2018","journal-title":"Int J Stroke"},{"key":"10.1016\/j.iccl.2019.05.002_bib83","article-title":"European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism","author":"Pristipino","year":"2018","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.iccl.2019.05.002_bib85","first-page":"859","article-title":"SCAI expert consensus statement on operator and\u00a0institutional requirements for PFO closure for secondary prevention of paradoxical embolic stroke: the American Academy of Neurology affirms the value of this statement as an educational tool for neurologists","volume":"93","author":"Horlick","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.iccl.2019.05.002_bib86","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00392-018-1305-4","article-title":"Patent foramen ovale closure for patients excluded from the randomized cryptogenic stroke trials","volume":"107","author":"Zaman","year":"2018","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"10.1016\/j.iccl.2019.05.002_bib87","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/jama.2017.21899","article-title":"Association of preoperatively diagnosed patent foramen ovale with perioperative ischemic stroke","volume":"319","author":"Ng","year":"2018","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.iccl.2019.05.002_bib88","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1161\/01.CIR.97.19.1946","article-title":"Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism","volume":"97","author":"Konstantinides","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.iccl.2019.05.002_bib89","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Trial of Org 10172 in Acute Stroke Treatment. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.iccl.2019.05.002_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000352050","article-title":"The\u00a0ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping)","volume":"36","author":"Amarenco","year":"2013","journal-title":"Cerebrovasc Dis"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745819300392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745819300392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:58:17Z","timestamp":1761933497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745819300392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S2211745819300392"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2019.05.002","relation":{},"ISSN":["2211-7458"],"issn-type":[{"value":"2211-7458","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcatheter Closure of Patent Foramen Ovale","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2019.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}